Latest Intestinal Ultrasound Advancements In Inflammatory Bowel Disease

Authors

  • Cathy Lu, MD, MSC Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Alberta

DOI:

https://doi.org/10.58931/cibdt.2024.2124

Abstract

Inflammatory bowel disease (IBD) treatment has evolved from monitoring clinical symptoms to targeting objective measurements of mucosal healing with endoscopic and radiologic imaging. It is well known that clinical symptoms do not match disease severity. Frequent evaluation with radiologic imaging is now the standard of care. Although Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE-II) recommendations do not list radiographic targets as an endpoint due to the “limited ability of the currently available treatments to achieve transmural healing,” this will likely evolve over time particularly with the rapidly growing uptake of intestinal ultrasound (IUS) in clinical trials. For the time being, imaging is considered as an “adjuvant assessment rather than a formal treatment target.”

Author Biography

Cathy Lu, MD, MSC, Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Alberta

Dr. Cathy Lu is a gastroenterologist and Assistant Professor at the University of Calgary. She completed a joint two year advanced IBD fellowship at the University of Alberta and the University of Calgary with specialization in intestinal ultrasound. She is an operational committee board member of the STAR (Stenosis, Therapy, and Anti-Fibrotic Research) Consortium and leads the development of the ultrasound index for Crohn’s disease strictures. She has also served as a member of the scientific committee for IBUS (the International Bowel Ultrasound Organization) and the Canadian Association of Gastroenterology. Dr. Lu currently co-chairs the scientific committee of iUS-CAN, the United States and Canada consortium for IUS. Her primary research interests are in fibrostenotic Crohn’s disease, intestinal ultrasound, and translational research identifying biomarkers in diagnosis, monitoring, and treatment response in IBD.

References

Turner D, Ricciuto A, Lewis A, D’Amico F, Dhaliwal J, Griffiths AM, et al. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD. Gastroenterology. 2021 Apr 1;160(5):1570–83. DOI: https://doi.org/10.1053/j.gastro.2020.12.031

Horsthuis K, Bipat S, Bennink RJ, Stoker J. Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies. Radiology. 2008 Apr;247(1):64–79. DOI: https://doi.org/10.1148/radiol.2471070611

Panés J, Bouzas R, Chaparro M, García-Sánchez V, Gisbert JP, Martínez de Guereñu B, et al. Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease. Aliment Pharmacol Ther. 2011;34(2):125–45. DOI: https://doi.org/10.1111/j.1365-2036.2011.04710.x

Bots S, Nylund K, Löwenberg M, Gecse K, D’Haens G. Intestinal Ultrasound to Assess Disease Activity in Ulcerative Colitis: Development of a novel UCUltrasound Index. J Crohns Colitis. 2021 Jan 7;15(8):1264–71. DOI: https://doi.org/10.1093/ecco-jcc/jjab002

de Voogd F, van Wassenaer EA, Mookhoek A, Bots S, van Gennep S, Löwenberg M, et al. Intestinal Ultrasound Is Accurate to Determine Endoscopic Response and Remission in Patients With Moderate to Severe Ulcerative Colitis: A Longitudinal Prospective Cohort Study. Gastroenterology. 2022 Dec 1;163(6):1569–81. DOI: https://doi.org/10.1053/j.gastro.2022.08.038

Miles A, Bhatnagar G, Halligan S, Gupta A, Tolan D, Zealley I, et al. Magnetic resonance enterography, small bowel ultrasound and colonoscopy to diagnose and stage Crohn’s disease: patient acceptability and perceived burden. Eur Radiol. 2019 Mar;29(3):1083–93. DOI: https://doi.org/10.1007/s00330-018-5661-2

Rohatinsky N, Zelinsky S, Dolinger M, Christensen B, Wilkens R, Radford S, et al. Crohn’s Disease Patient Experiences and Preferences With Disease Monitoring: An International Qualitative Study. Crohns Colitis 360. 2023 Apr 1;5(2):otad012. DOI: https://doi.org/10.1093/crocol/otad012

St-Pierre J, Delisle M, Kheirkhahrahimabadi H, Goodsall TM, Bryant RV, Christensen B, et al. Bedside Intestinal Ultrasound Performed in an Inflammatory Bowel Disease Urgent Assessment Clinic Improves Clinical Decision-Making and Resource Utilization. Crohns Colitis 360. 2023 Oct 1;5(4):otad050. DOI: https://doi.org/10.1093/crocol/otad050

Bezzio C, Saibeni S, Vernero M, Furfaro F, Monteleone M, Ribaldone D, et al. The learning curve for using intestinal ultrasonography. Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver. 2024 Feb 5;S1590-8658(24)00222-6. DOI: https://doi.org/10.1016/j.dld.2024.01.192

Novak KL, Nylund K, Maaser C, Petersen F, Kucharzik T, Lu C, et al. Expert Consensus on Optimal Acquisition and Development of the International Bowel Ultrasound Segmental Activity Score [IBUS-SAS]: A Reliability and Inter-rater Variability Study on Intestinal Ultrasonography in Crohn’s Disease. J Crohns Colitis. 2021 Apr 6;15(4):609–16. DOI: https://doi.org/10.1093/ecco-jcc/jjaa216

Ripollés T, Poza J, Suarez Ferrer C, Martínez-Pérez MJ, Martín-Algíbez A, de Las Heras Paez B. Evaluation of Crohn’s Disease Activity: Development of an Ultrasound Score in a Multicenter Study. Inflamm Bowel Dis. 2021 Jan 1;27(1):145–54. DOI: https://doi.org/10.1093/ibd/izaa134

Allocca M, Fiorino G, Bonovas S, Furfaro F, Gilardi D, Argollo M, et al. Accuracy of Humanitas Ultrasound Criteria in Assessing Disease Activity and Severity in Ulcerative Colitis: A Prospective Study. J Crohns Colitis. 2018 Nov 28;12(12):1385–91. DOI: https://doi.org/10.1093/ecco-jcc/jjy107

Sævik F, Eriksen R, Eide GE, Gilja OH, Nylund K. Development and Validation of a Simple Ultrasound Activity Score for Crohn’s Disease. J Crohns Colitis. 2021 Jan 13;15(1):115–24. DOI: https://doi.org/10.1093/ecco-jcc/jjaa112

Dubé C, Rostom A. Acquiring and maintaining competency in gastrointestinal endoscopy. Best Pract Res Clin Gastroenterol. 2016 Jun;30(3):339–47. DOI: https://doi.org/10.1016/j.bpg.2016.05.004

Burwash IG, Basmadjian A, Bewick D, Choy JB, Cujec B, Jassal DS, et al. 2010 Canadian Cardiovascular Society/Canadian Society of Echocardiography Guidelines for Training and Maintenance of Competency in Adult Echocardiography. Can J Cardiol. 2011;27(6):862–4. DOI: https://doi.org/10.1016/j.cjca.2011.03.003

Novak KL, Wilson SR. Sonography for surveillance of patients with Crohn disease. J Ultrasound Med Off J Am Inst Ultrasound Med. 2012 Aug;31(8):1147–52. DOI: https://doi.org/10.7863/jum.2012.31.8.1147

Fraquelli M, Sarno A, Girelli C, Laudi C, Buscarini E, Villa C, et al. Reproducibility of bowel ultrasonography in the evaluation of Crohn’s disease. Dig Liver Dis. 2008 Nov;40(11):860–6. DOI: https://doi.org/10.1016/j.dld.2008.04.006

Calabrese E, Kucharzik T, Maaser C, Maconi G, Strobel D, Wilson SR, et al. Real-time Interobserver Agreement in Bowel Ultrasonography for Diagnostic Assessment in Patients With Crohn’s Disease: An International Multicenter Study. Inflamm Bowel Dis. 2018;24(9 PG-2001–2006):2001–6. DOI: https://doi.org/10.1093/ibd/izy091

Castiglione F, Mainenti PP, De Palma GD, Testa A, Bucci L, Pesce G, et al. Noninvasive diagnosis of small bowel Crohn’s disease: direct comparison of bowel sonography and magnetic resonance enterography. Inflamm Bowel Dis. 2013 Apr;19(5):991–8. DOI: https://doi.org/10.1097/MIB.0b013e3182802b87

Parente F, Greco S, Molteni M, Cucino C, Maconi G, Sampietro GM, et al. Role of early ultrasound in detecting inflammatory intestinal disorders and identifying their anatomical location within the bowel. Aliment Pharmacol Ther. 2003 Nov 15;18(10):1009–16. DOI: https://doi.org/10.1046/j.1365-2036.2003.01796.x

Taylor SA, Mallett S, Bhatnagar G, Baldwin-Cleland R, Bloom S, Gupta A, et al. Diagnostic accuracy of magnetic resonance enterography and small bowel ultrasound for the extent and activity of newly diagnosed and relapsed Crohn’s disease (METRIC): a multicentre trial. Lancet Gastroenterol Hepatol. 2018 Aug;3(8):548–58.

Furfaro F, D’Amico F, Zilli A, Craviotto V, Aratari A, Bezzio C, et al. Noninvasive Assessment of Postoperative Disease Recurrence in Crohn’s Disease: A Multicenter, Prospective Cohort Study on Behalf of the Italian Group for Inflammatory Bowel Disease. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2023 Nov;21(12):3143–51. DOI: https://doi.org/10.1016/j.cgh.2022.11.039

Yung DE, Har-Noy O, Tham YS, Ben-Horin S, Eliakim R, Koulaouzidis A, et al. Capsule Endoscopy, Magnetic Resonance Enterography, and Small Bowel Ultrasound for Evaluation of Postoperative Recurrence in Crohn’s Disease: Systematic Review and Meta-Analysis. Inflamm Bowel Dis. 2018 Jan 1;24(1):93–100. DOI: https://doi.org/10.1093/ibd/izx027

Andreoli A, Cerro P, Falasco G, Giglio LA, Prantera C. Role of ultrasonography in the diagnosis of postsurgical recurrence of Crohn’s disease. Am J Gastroenterol. 1998 Jul;93(7):1117–21. DOI: https://doi.org/10.1111/j.1572-0241.1998.00340.x

Rispo A, Bucci L, Pesce G, Sabbatini F, de Palma GD, Grassia R, et al. Bowel sonography for the diagnosis and grading of postsurgical recurrence of Crohn’s disease. Inflamm Bowel Dis. 2006 Jun 1;12(6):486–90. DOI: https://doi.org/10.1097/00054725-200606000-00007

Parente F, Sampietro GM, Molteni M, Greco S, Anderloni A, Sposito C, et al. Behaviour of the bowel wall during the first year after surgery is a strong predictor of symptomatic recurrence of Crohn’s disease: a prospective study. Aliment Pharmacol Ther. 2004 Nov 1;20(9):959–68. DOI: https://doi.org/10.1111/j.1365-2036.2004.02245.x

Maconi G, Sampietro GM, Cristaldi M, Danelli PG, Russo A, Bianchi Porro G, et al. Preoperative characteristics and postoperative behavior of bowel wall on risk of recurrence after conservative surgery in Crohn’s disease: a prospective study. Ann Surg. 2001 Mar;233(3):345–52. DOI: https://doi.org/10.1097/00000658-200103000-00007

Fernandes SR, Rodrigues RV, Bernardo S, Cortez-Pinto J, Rosa I, da Silva JP, et al. Transmural Healing Is Associated with Improved Long-term Outcomes of Patients with Crohn’s Disease. Inflamm Bowel Dis. 2017 Aug;23(8):1403–9. DOI: https://doi.org/10.1097/MIB.0000000000001143

Fernandes SR, Serrazina J, Botto IA, Leal T, Guimarães A, Garcia JL, et al. Transmural remission improves clinical outcomes up to 5 years in Crohn’s disease. United Eur Gastroenterol J. 2022 Dec 27;11(1):51–9. DOI: https://doi.org/10.1002/ueg2.12356

Geyl S, Guillo L, Laurent V, D’Amico F, Danese S, Peyrin-Biroulet L. Transmural healing as a therapeutic goal in Crohn’s disease: a systematic review. Lancet Gastroenterol Hepatol. 2021 Aug 1;6(8):659–67. DOI: https://doi.org/10.1016/S2468-1253(21)00096-0

Ilvemark JFKF, Hansen T, Goodsall TM, Seidelin JB, Al-Farhan H, Allocca M, et al. Defining Transabdominal Intestinal Ultrasound Treatment Response and Remission in Inflammatory Bowel Disease: Systematic Review and Expert Consensus Statement. J Crohns Colitis. 2022 May 10;16(4):554–80. DOI: https://doi.org/10.1093/ecco-jcc/jjab173

Kucharzik T, Wilkens R, D’Agostino MA, Maconi G, Le Bars M, Lahaye M, et al. Early Ultrasound Response and Progressive Transmural Remission After Treatment With Ustekinumab in Crohn’s Disease. Clin Gastroenterol Hepatol. 2023 Jan 1;21(1):153-163.e12.

Gordon IO, Agrawal N, Willis E, Goldblum JR, Lopez R, Allende D, et al. Fibrosis in Ulcerative Colitis is Directly Linked to Severity and Chronicity of Mucosal Inflammation. Aliment Pharmacol Ther. 2018 Apr;47(7):922–39. DOI: https://doi.org/10.1111/apt.14526

Ma L, Li W, Zhuang N, Yang H, Liu W, Zhou W, et al. Comparison of transmural healing and mucosal healing as predictors of positive long-term outcomes in Crohn’s disease. Ther Adv Gastroenterol. 2021;14:1–11. DOI: https://doi.org/10.1177/17562848211016259

Allocca M, Dell’Avalle C, Craviotto V, Furfaro F, Zilli A, D’Amico F, et al. Predictive value of Milan ultrasound criteria in ulcerative colitis: A prospective observational cohort study. United Eur Gastroenterol J. 2022 Mar;10(2):190–7. DOI: https://doi.org/10.1002/ueg2.12206

Carter D, Albshesh A, Shimon C, Segal B, Yershov A, Kopylov U, et al. Automatized Detection of Crohn’s Disease in Intestinal Ultrasound Using Convolutional Neural Network. Inflamm Bowel Dis. 2023 Dec 1;29(12):1901–6. DOI: https://doi.org/10.1093/ibd/izad014

Rieder F, Bettenworth D, Ma C, Parker CE, Williamson LA, Nelson SA, et al. An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn’s disease. Aliment Pharmacol Ther. 2018 Aug;48(3):347–57. DOI: https://doi.org/10.1111/apt.14853

Allocca M, Dal Buono A, D’Alessio S, Spaggiari P, Garlatti V, Spinelli A, et al. Relationships Between Intestinal Ultrasound Parameters and Histopathologic Findings in a Prospective Cohort of Patients With Crohn’s Disease Undergoing Surgery. J Ultrasound Med Off J Am Inst Ultrasound Med. 2023 Aug;42(8):1717–28. DOI: https://doi.org/10.1002/jum.16191

Bhatnagar G, Rodriguez-Justo M, Higginson A, Bassett P, Windsor A, Cohen R, et al. Inflammation and fibrosis in Crohn’s disease: location-matched histological correlation of small bowel ultrasound features. Abdom Radiol N Y. 2021 Jan;46(1):144–55. DOI: https://doi.org/10.1007/s00261-020-02603-6

Pruijt MJ, de Voogd FAE, Montazeri NSM, van Etten-Jamaludin FS, D’Haens GR, Gecse KB. Diagnostic Accuracy of Intestinal Ultrasound in the Detection of Intra-Abdominal Complications in Crohn’s Disease: A Systematic Review and Meta-Analysis. J Crohns Colitis. 2024 Jan 4;jjad215. DOI: https://doi.org/10.1093/ecco-jcc/jjad215

Published

2024-06-05

How to Cite

1.
Lu C. Latest Intestinal Ultrasound Advancements In Inflammatory Bowel Disease. Can IBD Today [Internet]. 2024 Jun. 5 [cited 2024 Jun. 18];2(1):21–27. Available from: https://canadianibdtoday.com/article/view/2-1-lu

Issue

Section

Articles